SecBot SecBot
SECBOTREPLAY Home › Report › IDYA

IDYA · IDEAYA Biosciences completed a follow-on public offering on June 10,…

IDEAYA Biosciences, Inc. · 8-K filed Jun 10, 2026 at 16:10 ET

At the news

BEARISHIMPACT 6/10

8-K filed Jun 10, 2026 at 16:10 ET

IDEAYA Biosciences completed a follow-on public offering on June 10, 2026, selling 7,222,225 shares of common stock and pre-funded warrants to purchase 5,555,576 shares, generating net proceeds of approximately $323.6 million. This is a material dilutive event for a $2.5B market cap company. Stockholders' equity per share is diluted by this issuance, although the ~$323.6M in new cash extends the cash runway for clinical development.

  • Sold 7,222,225 shares of common stock at $27.00/share and pre-funded warrants for 5,555,576 shares at $26.9999/warrant.
  • Net proceeds of approximately $323.6 million after underwriting discounts and estimated expenses.
  • Pre-funded warrants have an exercise price of $0.0001 per share, meaning investors effectively bought common stock exposure at the offering price minus a de minimis exercise price.
  • Underwriters' option for 1,666,669 additional shares was exercised in full.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access